These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9449277)

  • 1. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.
    Brötz H; Bierbaum G; Leopold K; Reynolds PE; Sahl HG
    Antimicrob Agents Chemother; 1998 Jan; 42(1):154-60. PubMed ID: 9449277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
    Brötz H; Bierbaum G; Reynolds PE; Sahl HG
    Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?
    Brötz H; Bierbaum G; Markus A; Molitor E; Sahl HG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):714-9. PubMed ID: 7793878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.
    Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl HG
    Mol Microbiol; 1998 Oct; 30(2):317-27. PubMed ID: 9791177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus.
    Sass P; Jansen A; Szekat C; Sass V; Sahl HG; Bierbaum G
    BMC Microbiol; 2008 Oct; 8():186. PubMed ID: 18947397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity.
    Panina IS; Balandin SV; Tsarev AV; Chugunov AO; Tagaev AA; Finkina EI; Antoshina DV; Sheremeteva EV; Paramonov AS; Rickmeyer J; Bierbaum G; Efremov RG; Shenkarev ZO; Ovchinnikova TV
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari.
    Hammes WP; Neuhaus FC
    Antimicrob Agents Chemother; 1974 Dec; 6(6):722-8. PubMed ID: 4451345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ assay for identifying inhibitors of bacterial transglycosylase.
    Branstrom AA; Midha S; Goldman RC
    FEMS Microbiol Lett; 2000 Oct; 191(2):187-90. PubMed ID: 11024262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the lantibiotic mersacidin on the morphology of staphylococci.
    Molitor E; Kluczny C; Brötz H; Bierbaum G; Jack R; Sahl HG
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):318-28. PubMed ID: 8837393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis.
    Goldman RC; Gange D
    Curr Med Chem; 2000 Aug; 7(8):801-20. PubMed ID: 10828288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin.
    Majer F; Schmid DG; Altena K; Bierbaum G; Kupke T
    J Bacteriol; 2002 Mar; 184(5):1234-43. PubMed ID: 11844751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CbrA Mediates Colicin M Resistance in Escherichia coli through Modification of Undecaprenyl-Phosphate-Linked Peptidoglycan Precursors.
    Barreteau H; Patin D; Bouhss A; Blanot D; Mengin-Lecreulx D; Touzé T
    J Bacteriol; 2020 Nov; 202(23):. PubMed ID: 32958631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
    Breukink E; Wiedemann I; van Kraaij C; Kuipers OP; Sahl HG; de Kruijff B
    Science; 1999 Dec; 286(5448):2361-4. PubMed ID: 10600751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
    Hsu ST; Breukink E; Bierbaum G; Sahl HG; de Kruijff B; Kaptein R; van Nuland NA; Bonvin AM
    J Biol Chem; 2003 Apr; 278(15):13110-7. PubMed ID: 12562773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.
    Hashizume H; Sawa R; Harada S; Igarashi M; Adachi H; Nishimura Y; Nomoto A
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3821-8. PubMed ID: 21628543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
    Böttiger T; Schneider T; Martínez B; Sahl HG; Wiedemann I
    Appl Environ Microbiol; 2009 Jul; 75(13):4427-34. PubMed ID: 19429551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
    Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
    Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding.
    Goldman RC; Baizman ER; Longley CB; Branstrom AA
    FEMS Microbiol Lett; 2000 Feb; 183(2):209-14. PubMed ID: 10675585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.
    Szekat C; Jack RW; Skutlarek D; Färber H; Bierbaum G
    Appl Environ Microbiol; 2003 Jul; 69(7):3777-83. PubMed ID: 12839744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.